Testing cells from amniotic fluid to treat nerve diseases

Researchers are investigating whether a treatment called human amniotic mesenchymal cell secretome—a substance derived from cells found in amniotic fluid—can protect nerve cells and reduce inflammation associated with ALS and multiple sclerosis. This study is early-stage laboratory research, not a clinical trial where you would receive the treatment yourself. Instead, scientists will use your blood and skin samples to create miniature models of nerve tissue in the lab, then test whether this secretome can help those cells stay healthy.

ALS and multiple sclerosis are serious diseases that damage nerve cells and cause chronic inflammation in the brain and spinal cord. Current treatments have limitations, so researchers are exploring whether this natural cell-derived treatment might offer a new way to both protect nerve cells and calm the immune system's harmful activity.